106 related articles for article (PubMed ID: 9808531)
21. Two-step tumour targetting in ovarian cancer patients using biotinylated monoclonal antibodies and radioactive streptavidin.
Paganelli G; Belloni C; Magnani P; Zito F; Pasini A; Sassi I; Meroni M; Mariani M; Vignali M; Siccardi AG
Eur J Nucl Med; 1992; 19(5):322-9. PubMed ID: 1612093
[TBL] [Abstract][Full Text] [Related]
22. Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragments.
Casey JL; King DJ; Chaplin LC; Haines AM; Pedley RB; Mountain A; Yarranton GT; Begent RH
Br J Cancer; 1996 Nov; 74(9):1397-405. PubMed ID: 8912535
[TBL] [Abstract][Full Text] [Related]
23. Enhanced tumour uptake of radiolabelled antibodies by hyperthermia: Part I: Timing of injection relative to hyperthermia.
Hauck ML; Zalutsky MR
Int J Hyperthermia; 2005 Feb; 21(1):1-11. PubMed ID: 15764347
[TBL] [Abstract][Full Text] [Related]
24. Streptavidin in antibody pretargeting. 2. Evaluation Of methods for decreasing localization of streptavidin to kidney while retaining its tumor binding capacity.
Wilbur DS; Hamlin DK; Buhler KR; Pathare PM; Vessella RL; Stayton PS; To R
Bioconjug Chem; 1998; 9(3):322-30. PubMed ID: 9576806
[TBL] [Abstract][Full Text] [Related]
25. Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein.
Buchsbaum DJ; Khazaeli MB; Axworthy DB; Schultz J; Chaudhuri TR; Zinn KR; Carpenter M; LoBuglio AF
Clin Cancer Res; 2005 Nov; 11(22):8180-5. PubMed ID: 16299250
[TBL] [Abstract][Full Text] [Related]
26. A three-step strategy for targeting drug carriers to human ovarian carcinoma cells in vitro.
Xiao Z; McQuarrie SA; Suresh MR; Mercer JR; Gupta S; Miller GG
J Biotechnol; 2002 Mar; 94(2):171-84. PubMed ID: 11796170
[TBL] [Abstract][Full Text] [Related]
27. Role of biotin-binding affinity in streptavidin-based pretargeted radioimmunotherapy of lymphoma.
Hamblett KJ; Press OW; Meyer DL; Hamlin DK; Axworthy D; Wilbur DS; Stayton PS
Bioconjug Chem; 2005; 16(1):131-8. PubMed ID: 15656584
[TBL] [Abstract][Full Text] [Related]
28. Pretargeted radioimmunotherapy.
Meredith RF; Buchsbaum DJ
Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S57-9. PubMed ID: 16979441
[TBL] [Abstract][Full Text] [Related]
29. Targeting strategies for cancer radiotherapy.
Buchsbaum DJ; Rogers BE; Khazaeli MB; Mayo MS; Milenic DE; Kashmiri SV; Anderson CJ; Chappell LL; Brechbiel MW; Curiel DT
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
[TBL] [Abstract][Full Text] [Related]
30. Biological comparison of 149Pm-, 166Ho-, and 177Lu-DOTA-biotin pretargeted by CC49 scFv-streptavidin fusion protein in xenograft-bearing nude mice.
Lewis MR; Zhang J; Jia F; Owen NK; Cutler CS; Embree MF; Schultz J; Theodore LJ; Ketring AR; Jurisson SS; Axworthy DB
Nucl Med Biol; 2004 Feb; 31(2):213-23. PubMed ID: 15013487
[TBL] [Abstract][Full Text] [Related]
31. Improved tumor targeting and decreased normal tissue accumulation through extracorporeal affinity adsorption in a two-step pretargeting strategy.
Mårtensson L; Nilsson R; Ohlsson T; Sjögren HO; Strand SE; Tennvall J
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5572s-5576s. PubMed ID: 17875791
[TBL] [Abstract][Full Text] [Related]
32. Improving tumor-to-normal-tissue ratios of antibodies by extracorporeal immunoadsorption based on the avidin-biotin concept: development of a new treatment strategy applied to monoclonal antibodies murine L6 and chimeric BR96.
Tennvall J; Garkavij M; Chen J; Sjögren HO; Strand SE
Cancer; 1997 Dec; 80(12 Suppl):2411-8. PubMed ID: 9406691
[TBL] [Abstract][Full Text] [Related]
33. The effect of second antibody clearance on the distribution and dosimetry of radiolabelled anti-CEA antibody in a human colonic tumor xenograft model.
Pedley RB; Dale R; Boden JA; Begent RH; Keep PA; Green AJ
Int J Cancer; 1989 Apr; 43(4):713-8. PubMed ID: 2539334
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibody Po66 uptake by human lung tumours implanted in nude mice: effect of co-administration with doxorubicin.
Desrues B; Léna H; Brichory F; Ramée MP; Toujas L; Delaval P; Dazord L
Br J Cancer; 1995 Nov; 72(5):1076-82. PubMed ID: 7577450
[TBL] [Abstract][Full Text] [Related]
35. Rapid and specific targeting of monoclonal antibody A33 to a colon cancer xenograft in nude mice.
Barendswaard EC; Scott AM; Divgi CR; Williams C; Coplan K; Riedel E; Yao TJ; Gansow OA; Finn RD; Larson SM; Old LJ; Welt S
Int J Oncol; 1998 Jan; 12(1):45-53. PubMed ID: 9454885
[TBL] [Abstract][Full Text] [Related]
36. Orthotopic xenografts of human melanoma and colonic and ovarian carcinoma in sheep to evaluate radioimmunotherapy.
Turner JH; Rose AH; Glancy RJ; Penhale WJ
Br J Cancer; 1998 Aug; 78(4):486-94. PubMed ID: 9716032
[TBL] [Abstract][Full Text] [Related]
37. A two-step targeting approach for delivery of doxorubicin-loaded liposomes to tumour cells in vivo.
Longman SA; Cullis PR; Choi L; de Jong G; Bally MB
Cancer Chemother Pharmacol; 1995; 36(2):91-101. PubMed ID: 7767956
[TBL] [Abstract][Full Text] [Related]
38. Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization.
Casalini P; Luison E; Ménard S; Colnaghi MI; Paganelli G; Canevari S
J Nucl Med; 1997 Sep; 38(9):1378-81. PubMed ID: 9293791
[TBL] [Abstract][Full Text] [Related]
39. Use of galactosylated-streptavidin as a clearing agent with 111In-labeled, biotinylated antibodies to enhance tumor/non-tumor localization ratios.
Govindan SV; Griffiths GL; Michel RB; Andrews PM; Goldenberg DM; Mattes MJ
Cancer Biother Radiopharm; 2002 Jun; 17(3):307-16. PubMed ID: 12136523
[TBL] [Abstract][Full Text] [Related]
40. Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.
Gerretsen M; Schrijvers AH; van Walsum M; Braakhuis BJ; Quak JJ; Meijer CJ; Snow GB; van Dongen GA
Br J Cancer; 1992 Sep; 66(3):496-502. PubMed ID: 1520586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
